ebomi
Colour theme
Sign in
Insider · CIK 0001388325

Novo Holdings A/S

CIK 0001388325 Name as filed on the most recent filing

Filed as Novo Holdings A/S (66)· Novo A/S (69)

724 transaction lines · from 135 filings · filed 2007-02-02 to 2026-05-05 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised. The 40 most recent are shown; the catalog may hold more for this insider.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

724 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-05-01 P, Open-market purchase Avalyn Pharma Inc.AVLN 9,999,990, acquired Open Form 4 filing 0001388325-26-000021
2025-10-28 P, Open-market purchase MapLight Therapeutics, Inc.MPLT 16,199,997, acquired Open Form 4 filing 0001388325-25-000018
2024-07-26 S, Open-market sale IO Biotech, Inc.IOBT 30,787, disposed Open Form 4 filing 0000950170-24-087061
2024-07-25 S, Open-market sale IO Biotech, Inc.IOBT 68,339, disposed Open Form 4 filing 0000950170-24-087061
2024-05-10 S, Open-market sale IO Biotech, Inc.IOBT 802,495, disposed Open Form 4 filing 0000950170-24-059965
2024-03-21 S, Open-market sale Spruce Biosciences, Inc.SPRB 350,951, disposed Open Form 4 filing 0001209191-24-005075
2024-03-20 S, Open-market sale Spruce Biosciences, Inc.SPRB 264,081, disposed Open Form 4 filing 0001209191-24-005017
2024-03-19 S, Open-market sale Spruce Biosciences, Inc.SPRB 447,715, disposed Open Form 4 filing 0001209191-24-005017
2024-03-18 S, Open-market sale Spruce Biosciences, Inc.SPRB 647,008, disposed Open Form 4 filing 0001209191-24-005017
2024-03-14 S, Open-market sale Spruce Biosciences, Inc.SPRB 1,698,902, disposed Open Form 4 filing 0001209191-24-004900
2024-02-13 P, Open-market purchase Metagenomi, Inc.MGX 12,000,000, acquired Open Form 4 filing 0001209191-24-003423
2024-02-09 S, Open-market sale IO Biotech, Inc.IOBT 988,411, disposed Open Form 4 filing 0001209191-24-003303
2024-02-09 P, Open-market purchase Metagenomi, Inc.MGX 1,025,000, acquired Open Form 4 filing 0001209191-24-003423
2023-08-09 P, Open-market purchase IO Biotech, Inc.IOBT 4,999,998, acquired Open Form 4 filing 0001209191-23-045444
2023-07-20 S, Open-market sale Cyteir Therapeutics, Inc.CYT 275,140, disposed Open Form 4 filing 0001209191-23-042977
2023-07-19 S, Open-market sale Cyteir Therapeutics, Inc.CYT 5,247, disposed Open Form 4 filing 0001209191-23-042977
2023-07-18 S, Open-market sale Cyteir Therapeutics, Inc.CYT 17,923, disposed Open Form 4 filing 0001209191-23-042670
2023-07-17 S, Open-market sale Cyteir Therapeutics, Inc.CYT 58,000, disposed Open Form 4 filing 0001209191-23-042670
2023-07-14 S, Open-market sale Cyteir Therapeutics, Inc.CYT 30,102, disposed Open Form 4 filing 0001209191-23-042670
2023-06-30 S, Open-market sale Cyteir Therapeutics, Inc.CYT 529,288, disposed Open Form 4 filing 0001209191-23-040691
2023-06-28 S, Open-market sale Disc Medicine, Inc.IRON 57,625,000, disposed Open Form 4 filing 0001209191-23-040057
2023-06-27 S, Open-market sale Cyteir Therapeutics, Inc.CYT 56,687, disposed Open Form 4 filing 0001209191-23-040129
2023-06-26 S, Open-market sale Cyteir Therapeutics, Inc.CYT 15,106, disposed Open Form 4 filing 0001209191-23-040129
2023-06-23 S, Open-market sale Cyteir Therapeutics, Inc.CYT 6,447, disposed Open Form 4 filing 0001209191-23-039545
2023-06-23 S, Open-market sale Reneo Pharmaceuticals, Inc.RPHM 709,740, disposed Open Form 4 filing 0001209191-23-039541
2023-06-22 S, Open-market sale Cyteir Therapeutics, Inc.CYT 9,783, disposed Open Form 4 filing 0001209191-23-039545
2023-06-21 S, Open-market sale Cyteir Therapeutics, Inc.CYT 9,641, disposed Open Form 4 filing 0001209191-23-039545
2023-06-20 S, Open-market sale Cyteir Therapeutics, Inc.CYT 1,573, disposed Open Form 4 filing 0001209191-23-038567
2023-06-16 S, Open-market sale Cyteir Therapeutics, Inc.CYT 12,142, disposed Open Form 4 filing 0001209191-23-038567
2023-06-15 S, Open-market sale Cyteir Therapeutics, Inc.CYT 20,304, disposed Open Form 4 filing 0001209191-23-038567
2023-06-14 S, Open-market sale Cyteir Therapeutics, Inc.CYT 6,050, disposed Open Form 4 filing 0001209191-23-037208
2023-06-13 S, Open-market sale Cyteir Therapeutics, Inc.CYT 5,515, disposed Open Form 4 filing 0001209191-23-037208
2023-06-12 S, Open-market sale Cyteir Therapeutics, Inc.CYT 1,858, disposed Open Form 4 filing 0001209191-23-037208
2023-02-16 P, Open-market purchase Spruce Biosciences, Inc.SPRB 6,999,360, acquired Open Form 4 filing 0001209191-23-011156
2022-09-14 P, Open-market purchase Edgewise Therapeutics, Inc.EWTX 4,999,999, acquired Open Form 4 filing 0001209191-22-050258
2022-07-20 S, Open-market sale Cyteir Therapeutics, Inc.CYT 2,700,000, disposed Open Form 4 filing 0001209191-22-043049
2022-07-13 S, Open-market sale Bolt Biotherapeutics, Inc.BOLT 1,600,000, disposed Open Form 4 filing 0001209191-22-042241
2022-02-25 S, Open-market sale Checkmate Pharmaceuticals, Inc.CMPI 811, disposed Open Form 4 filing 0001209191-22-013316
2022-02-24 S, Open-market sale Checkmate Pharmaceuticals, Inc.CMPI 16,979, disposed Open Form 4 filing 0001209191-22-013316
2022-02-23 S, Open-market sale Checkmate Pharmaceuticals, Inc.CMPI 5,277, disposed Open Form 4 filing 0001209191-22-013316
2022-02-08 P, Open-market purchase Arcellx, Inc.ACLX 12,499,995, acquired Open Form 4 filing 0001209191-22-008145
2021-11-09 P, Open-market purchase IO Biotech, Inc.IOBT 4,550,000, acquired Open Form 4 filing 0001209191-21-063969
2021-10-26 P, Open-market purchase Minerva Surgical IncUTRS 6,960,000, acquired Open Form 4 filing 0001209191-21-061795
2021-06-22 P, Open-market purchase Cyteir Therapeutics, Inc.CYT 4,999,986, acquired Open Form 4 filing 0001209191-21-042786
2021-06-21 P, Open-market purchase Verve Therapeutics, Inc.VERV 6,650,000, acquired Open Form 4 filing 0001209191-21-042452
2021-06-02 S, Open-market sale Inogen IncINGN 38,977,600, disposed Open Form 4 filing 0001209191-21-037932
2021-05-19 S, Open-market sale Spruce Biosciences, Inc.SPRB 6,602,500, disposed Open Form 4 filing 0001209191-21-034923
2021-04-13 P, Open-market purchase Reneo Pharmaceuticals, Inc.RPHM 9,999,990, acquired Open Form 4 filing 0001209191-21-026667
2021-03-30 P, Open-market purchase Edgewise Therapeutics, Inc.EWTX 10,000,000, acquired Open Form 4 filing 0001209191-21-023779
2021-03-01 S, Open-market sale Inogen IncINGN 38,710,000, disposed Open Form 4 filing 0001209191-21-016876

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
%, Ten percent owner
Ten percent owner

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 609
  • Open-market sale 115
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Novo Holdings A/S, insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001388325

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.